in

Pfizer-BioNTech raises 2021 vaccine sales forecast to $33.5 billion


The vaccine produced by the US pharmaceutical firm Pfizer and the Germany-based biotechnology firm BioNTech in keeping with their efforts to fight coronavirus is utilized by another nations, together with Turkey.

Pfizer, in a press release, raised its forecast for the sales of the coronavirus vaccine.

28.8 PERCENT INCREASE EXPECTED

The corporate stated it expects sales of vaccines price $33.5 billion this yr, up 28.8 %.

It was famous that the rising sales forecast of the vaccine is predicated on the agreements signed for two.1 billion doses this yr, and the quantity might enhance if further contracts are made.

MORE SALES PROJECT IN 2022

Pfizer and BioNTech plan to produce 3 billion doses of vaccine this yr.

The US-based firm shared its view {that a} third “booster” dose of the coronavirus vaccine might be wanted sooner or later, saying this is able to imply extra vaccine sales in 2022.

50-50 AGREEMENT

The corporate in query famous that it might apply for an emergency use allow in early August for a potential booster dose.

The prices and income of the vaccine are shared 50-50 % between Pfizer and BioNTech.

#PfizerBioNTech #raises #vaccine #sales #forecast #billion

Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.


https://m.ensonhaber.com/dunya/pfizer-biontech-2021-asi-satis-tahminini-335-milyar-dolara-yukseltti
You May Also Like:  Texas Governor, who banned mask requirement in the USA, caught corona

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

5 steps parents with special children should follow

What are the benefits of Andız molasses? What is Andız molasses good for, how is it consumed?